← The Lantern · New Carlisle
health · class ii

Teva Pharmaceuticals USA, Inc. recalls Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle

Hinjwadi, Pune, India, Manufa… beginning May 16, 2012, in a drug recall whose distribution included Ohio.

Illustration: a pharmacy counter with pill bottles, a blister pack and one bottle set aside
Illustration · The Lantern

Teva Pharmaceuticals USA, Inc. began a drug recall on May 16, 2012 whose reported distribution included Ohio. FDA

What the record shows

recalled Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. The stated reason: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight) FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 2,268 bottles. The recall is listed as terminated. FDA

1 source

Context

This is one of 2 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2882 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: May 16, 2012 FDA
  • Recall number: D-1409-2012 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Teva Pharmaceuticals USA, Inc. FDA
  • Product: Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals… FDA
  • Reason for recall: Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight) FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberD-1409-2012
Recalls in this action1
Recalling firmTeva Pharmaceuticals USA, Inc.
ProductMetoprolol Tartrate Tablets USP 50 mg, 1000 count bottle, Rx only, Manufactured in india By: Emcure Pharmaceuticals LTD. Hinjwadi, Pune, India, Manufactured for TEVA Phamaceuticals USA, Sellersville, PA 18960, NDC 0093-0733-10
Reason for recallTablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typedrug
Quantity2,268 bottles
StatusTerminated
Voluntary or mandatedVoluntary: Firm initiated
Initiated20120516
Reported20120711
DistributionOhio
Firm locationSellersville, PA, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.